Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of remimazolam for anesthesia induction in pediatric snoring surgery
ChiCTR2500102600Phase 3Not yet recruiting
- Sponsor
- Ningde Mindong Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of remimazolam in Snoring and obstructive sleep-disordered breathing (OSA) (3 arms), sponsored by Ningde Mindong Hospital. Primary endpoints: ED90 and Incidence of hypotension. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Snoringobstructive sleep-disordered breathing (OSA)
Beyond the preview
Go deeper on ChiCTR2500102600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102600.